WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H563199
CAS#: 329939-05-1
Description: OX3a is an orco antagonist. It acts by inhibiting odorant activation of insect Ors.
Hodoodo Cat#: H563199
Name: OX3a
CAS#: 329939-05-1
Chemical Formula: C13H13NOS
Exact Mass: 231.07
Molecular Weight: 231.310
Elemental Analysis: C, 67.50; H, 5.67; N, 6.06; O, 6.92; S, 13.86
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: OX3a; OX-3a; OX 3a;
IUPAC/Chemical Name: N-(4-Methylbenzyl)-2-thiophenecarboxamide
InChi Key: NUQVSGQAALWHLJ-UHFFFAOYSA-N
InChi Code: InChI=1S/C13H13NOS/c1-10-4-6-11(7-5-10)9-14-13(15)12-3-2-8-16-12/h2-8H,9H2,1H3,(H,14,15)
SMILES Code: O=C(C1=CC=CS1)NCC2=CC=C(C)C=C2
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 231.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Bertin Y, Boukhors K, Pradel N, Livrelli V, Martin C. Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors. J Clin Microbiol. 2001 Sep;39(9):3060-5. PubMed PMID: 11526129; PubMed Central PMCID: PMC88297.
2: Ramachandran V, Hornitzky MA, Bettelheim KA, Walker MJ, Djordjevic SP. The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type. J Clin Microbiol. 2001 May;39(5):1932-7. PubMed PMID: 11326016; PubMed Central PMCID: PMC88051.
3: Paton AW, Bourne AJ, Manning PA, Paton JC. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Infect Immun. 1995 Jul;63(7):2450-8. PubMed PMID: 7790056; PubMed Central PMCID: PMC173327.